advertisement
Eye 129
Showing records 1 to 25 | Display all abstracts in Eye112637 Impact of Type 2 diabetes mellitus and insulin use on progression to glaucoma surgery in primary open angle glaucoma
Sun MT
Eye 2024; 38: 558-564
112445 The impact of visual function on staircase use performance in glaucoma
Su CC
Eye 2024; 38: 357-363
113412 The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results
Khanani AM
Eye 2023; 37: 3574-3581
113270 Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan
Fujita A
Eye 2024; 38: 930-936
111913 African American patient-provider communication about glaucoma vision quality-of-life
Sleath B
Eye 2024; 38: 343-348
112876 Detection and agreement of event-based OCT and OCTA analysis for glaucoma progression
Wu JH
Eye 2024; 38: 973-979
112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Sakata R
Eye 2024; 38: 737-744
112843 Outcomes of newly referred patients with suspected angle closure: do we need to redefine the clinical pathways?
Founti P
Eye 2024; 38: 514-519
113300 Smoking, alcohol consumption and corneal biomechanical parameters among Chinese university students
Liu MX
Eye 2023; 37: 2723-2729
112917 Prevalence and clinical characteristics of uveitic glaucoma: multicentric study in Bogotá, Colombia
Rojas-Carabali W
Eye 2024; 38: 714-722
113043 Classifying glaucoma exclusively with OCT: comparison of three clustering algorithms derived from machine learning
Biarnés M
Eye 2024; 38: 841-846
112829 Mapping vision loss of patients in a glaucoma backlog following the COVID-19 pandemic: a real-world analysis using the Glauc-Strat-Fast risk stratification tool
Sharma O
Eye 2024; 38: 1005-1011
112649 Providing capacity in glaucoma care using trained and accredited optometrists: A qualitative evaluation
Gunn PJG
Eye 2024; 38: 994-1004
112863 Incidence of primary open angle glaucoma in the Andhra Pradesh Eye Disease Study (APEDS)
Choudhari NS
Eye 2024; 38: 2179-2186
113045 Long-term outcomes of Mitomycin-C augmented trabeculectomy using subconjunctival injections versus soaked sponges: a randomised controlled trial
Maheshwari D
Eye 2024; 38: 968-972
112800 Utility of targeted mean total deviation trend analysis for detecting progressive visual field changes in early-to-moderate stage glaucoma
Song WK
Eye 2024; 38: 545-552
112475 Clinical characteristics of open-angle glaucoma progression with peripapillary microvasculature dropout in different locations
Lee JS
Eye 2024; 38: 284-291
113412 The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results
Aziz AA
Eye 2023; 37: 3574-3581
113043 Classifying glaucoma exclusively with OCT: comparison of three clustering algorithms derived from machine learning
Ventura-Abreu N
Eye 2024; 38: 841-846
112649 Providing capacity in glaucoma care using trained and accredited optometrists: A qualitative evaluation
Read S
Eye 2024; 38: 994-1004
113045 Long-term outcomes of Mitomycin-C augmented trabeculectomy using subconjunctival injections versus soaked sponges: a randomised controlled trial
Pillai MR
Eye 2024; 38: 968-972
112637 Impact of Type 2 diabetes mellitus and insulin use on progression to glaucoma surgery in primary open angle glaucoma
Pershing S
Eye 2024; 38: 558-564
112876 Detection and agreement of event-based OCT and OCTA analysis for glaucoma progression
Moghimi S
Eye 2024; 38: 973-979
113300 Smoking, alcohol consumption and corneal biomechanical parameters among Chinese university students
Li DL
Eye 2023; 37: 2723-2729
112445 The impact of visual function on staircase use performance in glaucoma
Wang TH
Eye 2024; 38: 357-363
